Literature DB >> 33291284

Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective.

Manuela Curcio1, Giuseppe Cirillo1, Jourdin R C Rouaen2,3, Federica Saletta2, Fiore Pasquale Nicoletta1, Orazio Vittorio2,3,4, Francesca Iemma1.   

Abstract

Targeted drug delivery systems represent valuable tools to enhance the accumulation of therapeutics in the brain. Here, the presence of the blood brain barrier strongly hinders the passage of foreign substances, often limiting the effectiveness of pharmacological therapies. Among the plethora of materials used for the development of these systems, natural polysaccharides are attracting growing interest because of their biocompatibility, muco-adhesion, and chemical versatility which allow a wide range of carriers with tailored physico-chemical features to be synthetized. This review describes the state of the art in the field of targeted carriers based on natural polysaccharides over the last five years, focusing on the main targeting strategies, namely passive and active transport, stimuli-responsive materials and the administration route. In addition, in the last section, the efficacy of the reviewed carriers in each specific brain diseases is summarized and commented on in terms of enhancement of either blood brain barrier (BBB) permeation ability or drug bioavailability in the brain.

Entities:  

Keywords:  brain diseases; drug delivery; nanocarriers; polysaccharides

Year:  2020        PMID: 33291284      PMCID: PMC7762150          DOI: 10.3390/pharmaceutics12121183

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  118 in total

1.  Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models.

Authors:  N Joan Abbott
Journal:  Drug Discov Today Technol       Date:  2004-12

2.  Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.

Authors:  Kousalya Selvaraj; Kuppusamy Gowthamarajan; Veera Venkata Satyanarayana Reddy Karri
Journal:  Artif Cells Nanomed Biotechnol       Date:  2017-12-28       Impact factor: 5.678

3.  Stabilization of Human Tyrosine Hydroxylase in Maltodextrin Nanoparticles for Delivery to Neuronal Cells and Tissue.

Authors:  Maria T Bezem; Fredrik G Johannessen; Kunwar Jung-Kc; Edvin Tang Gundersen; Ana Jorge-Finnigan; Ming Ying; Didier Betbeder; Lars Herfindal; Aurora Martinez
Journal:  Bioconjug Chem       Date:  2018-01-31       Impact factor: 4.774

4.  Gamma radiation preparation of chitosan nanoparticles for controlled delivery of memantine.

Authors:  Rasha R Radwan; Ashraf M Abdel Ghaffar; Hussein E Ali
Journal:  J Biomater Appl       Date:  2019-11-26       Impact factor: 2.646

5.  Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells.

Authors:  P Ramge; R E Unger; J B Oltrogge; D Zenker; D Begley; J Kreuter; H Von Briesen
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

6.  Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.

Authors:  Ebtsam M Abdou; Soha M Kandil; Hala M F El Miniawy
Journal:  Int J Pharm       Date:  2017-07-17       Impact factor: 5.875

7.  Synthesis and characterization of novel chitosan-dopamine or chitosan-tyrosine conjugates for potential nose-to-brain delivery.

Authors:  Roberta Cassano; Adriana Trapani; Maria Luisa Di Gioia; Delia Mandracchia; Rosalia Pellitteri; Giuseppe Tripodo; Sonia Trombino; Sante Di Gioia; Massimo Conese
Journal:  Int J Pharm       Date:  2020-08-30       Impact factor: 5.875

Review 8.  Progress and perspectives on targeting nanoparticles for brain drug delivery.

Authors:  Huile Gao
Journal:  Acta Pharm Sin B       Date:  2016-06-14       Impact factor: 11.413

Review 9.  Polysaccharide nanosystems for future progress in cardiovascular pathologies.

Authors:  Amanda Karine Andriola Silva; Didier Letourneur; Cédric Chauvierre
Journal:  Theranostics       Date:  2014-03-11       Impact factor: 11.556

10.  Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).

Authors:  Maxim Shevtsov; Boris Nikolaev; Yaroslav Marchenko; Ludmila Yakovleva; Nikita Skvortsov; Anton Mazur; Peter Tolstoy; Vyacheslav Ryzhov; Gabriele Multhoff
Journal:  Int J Nanomedicine       Date:  2018-03-12
View more
  1 in total

1.  Crosslinked Chitosan-Gelatin Biocompatible Nanocomposite as a Neuro Drug Carrier.

Authors:  Sheril Ann Mathew; Stephen Arumainathan
Journal:  ACS Omega       Date:  2022-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.